相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?
J. A. Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Precision Medicine
M. Pacanowski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
DRD and GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson's disease patients
Shahidee Zainal Abidin et al.
BMC NEUROLOGY (2015)
Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease
Caroline Moreau et al.
BRAIN (2015)
Neuroprotection in Parkinson's disease: a difficult challenge
Fabrizio Stocchi
LANCET NEUROLOGY (2015)
BDNF polymorphism associates with decline in set shifting in Parkinson's disease
Nicolien M. van der Kolk et al.
NEUROBIOLOGY OF AGING (2015)
Time to change the blind men and the elephant approach to Parkinson disease?
Brad A. Racette et al.
NEUROLOGY (2015)
Neuroscience With Modern Concepts of Impulse Control Disorders in Parkinson's Disease
T. Celeste Napier et al.
MOVEMENT DISORDERS (2015)
Clinical Spectrum of Impulse Control Disorders in Parkinson's Disease
Daniel Weintraub et al.
MOVEMENT DISORDERS (2015)
GBA-Associated Parkinson's Disease: Reduced Survival and More Rapid Progression in a Prospective Longitudinal Study
Kathrin Brockmann et al.
MOVEMENT DISORDERS (2015)
Cognitive, Neuropsychiatric, and Motor Features Associated With Apolipoprotein E ε4 Allele in a Sample of Bulgarian Patients With Late-Onset Parkinson's Disease
Radka Pavlova et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2014)
Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study
Cristina Nombela et al.
BRAIN (2014)
Cry1 and Tef gene polymorphisms are associated with major depressive disorder in the Chinese population
Ping Hua et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Sequence Variants in SLC6A3, DRD2, and BDNF Genes and Time to Levodopa-Induced Dyskinesias in Parkinson's Disease
Natalie Kaplan et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2014)
Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study
Pedro J. Garcia-Ruiz et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
The neurobiological basis of cognitive impairment in Parkinson's disease
Glenda M. Halliday et al.
MOVEMENT DISORDERS (2014)
BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease
Monika Bialecka et al.
NEUROSCIENCE LETTERS (2014)
Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population
Hongying Hao et al.
PARKINSONISM & RELATED DISORDERS (2014)
Catechol-O-methyltransferase Val158Met polymorphism: Modulation of wearing-off susceptibility in a Chinese cohort of Parkinson's disease
Hui Wu et al.
PARKINSONISM & RELATED DISORDERS (2014)
APOE, MAPT, and SNCA Genes and Cognitive Performance in Parkinson Disease
Ignacio F. Mata et al.
JAMA NEUROLOGY (2014)
Predicting cognitive decline in Parkinson's disease: can we ask the genes?
Fabiola De Marchi et al.
FRONTIERS IN NEUROLOGY (2014)
Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort
Sophie E. Winder-Rhodes et al.
BRAIN (2013)
No Association between Brain-Derived Neurotrophic Factor G196A Polymorphism and Clinical Features of Parkinson's Disease
Marina Svetel et al.
EUROPEAN NEUROLOGY (2013)
Circadian and sleep disorders in Parkinson's disease
Aleksandar Videnovic et al.
EXPERIMENTAL NEUROLOGY (2013)
Polymorphisms in the dopamine transporter gene are associated with visual hallucinations and levodopa equivalent dose in Brazilians with Parkinson's disease
Artur F. Schumacher-Schuh et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Trial Designs Used to Study Neuroprotective Therapy in Parkinson's Disease
Anthony E. Lang et al.
MOVEMENT DISORDERS (2013)
Impulse Control and Related Disorders in Parkinson's Disease
Daniel Weintraub et al.
NEURODEGENERATIVE DISEASES (2013)
Screening for impulse control symptoms in patients with de novo Parkinson disease A case-control study
Daniel Weintraub et al.
NEUROLOGY (2013)
Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies
Ariana P. Gatt et al.
NEUROSCIENCE LETTERS (2013)
Clinical and Biochemical Differences in Patients Having Parkinson Disease With vs Without GBA Mutations
Lama M. Chahine et al.
JAMA NEUROLOGY (2013)
Neuropathologic substrates of Parkinson disease dementia
David J. Irwin et al.
ANNALS OF NEUROLOGY (2012)
The six gaps in the search of neuroprotection for Parkinson's disease
Alberto J. Espay et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
Association of monoamine oxidase B and catechol-O-methyltransferase polymorphisms with sporadic Parkinson's disease in an Iranian population
Anahita Torkaman-Boutorabi et al.
FOLIA NEUROPATHOLOGICA (2012)
Serotonergic involvement in levodopa-induced dyskinesias in Parkinson's disease
Perdita A. Cheshire et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
Sleep disorders in Parkinson's disease: Many causes, few therapeutic options
Nico J. Diederich et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment
Per Svenningsson et al.
LANCET NEUROLOGY (2012)
Catechol-O-methyltransferase Val158Met and the Risk of Dyskinesias in Parkinson's Disease
Lonneke M. L. de lau et al.
MOVEMENT DISORDERS (2012)
Association of Tef polymorphism with depression in Parkinson disease
Ping Hua et al.
MOVEMENT DISORDERS (2012)
Genetic influences on cognitive decline in Parkinson's disease
James F. Morley et al.
MOVEMENT DISORDERS (2012)
DLB and PDD: a role for mutations in dementia and Parkinson disease genes?
Bram Meeus et al.
NEUROBIOLOGY OF AGING (2012)
Cognitive performance of GBA mutation carriers with early-onset PD The CORE-PD study
R. N. Alcalay et al.
NEUROLOGY (2012)
Genetic variant of HTR2A associates with risk of impulse control and repetitive behaviors in Parkinson's disease
Jee-Young Lee et al.
PARKINSONISM & RELATED DISORDERS (2012)
Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders
Annamaria Vallelunga et al.
PARKINSONISM & RELATED DISORDERS (2012)
DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson's disease patients
Mariana Rieck et al.
PHARMACOGENOMICS (2012)
Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson's Disease
Oliver Cooper et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
The role of apolipoprotein E polymorphisms in levodopa-induced dyskinesia
I. Molchadski et al.
ACTA NEUROLOGICA SCANDINAVICA (2011)
Converging Evidence Implicates the Dopamine D3 Receptor Gene in Vulnerability to Schizophrenia
Fuquan Zhang et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2011)
Therapies for Dopaminergic-Induced Dyskinesias in Parkinson Disease
Mildred D. Gottwald et al.
ANNALS OF NEUROLOGY (2011)
The COMT Val158Met Polymorphism Affects the Response to Entacapone in Parkinson's Disease: A Randomized Crossover Clinical Trial
Jean-Christophe Corvol et al.
ANNALS OF NEUROLOGY (2011)
Pharmacological treatment and the prospect of pharmacogenetics in Parkinson's disease
K. Kalinderi et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1)
Johanne H. Somme et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Differential Genetic Susceptibility in Diphasic and Peak-Dose Dyskinesias in Parkinson's Disease
Jee-Young Lee et al.
MOVEMENT DISORDERS (2011)
Disease-Related and Genetic Correlates of Psychotic Symptoms in Parkinson's Disease
Stewart A. Factor et al.
MOVEMENT DISORDERS (2011)
The Motor Phenotype of Parkinson's Disease in Relation to Age at Onset
Mirdhu M. Wickremaratchi et al.
MOVEMENT DISORDERS (2011)
GBA-associated PD presents with nonmotor characteristics
K. Brockmann et al.
NEUROLOGY (2011)
TrkB receptor controls striatal formation by regulating the number of newborn striatal neurons
Maryna Baydyuk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Family and parenting characteristics associated with marijuana use by Chilean adolescents
Cristina B. Bares et al.
SUBSTANCE ABUSE AND REHABILITATION (2011)
Genetic and environmental influences on impulsivity: A meta-analysis of twin, family and adoption studies
Serena Bezdjian et al.
CLINICAL PSYCHOLOGY REVIEW (2011)
Brain-derived neurotrophic factor G196A polymorphism and clinical features in Parkinson's disease
L. Gao et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Maladaptive Plasticity of Serotonin Axon Terminals in Levodopa-Induced Dyskinesia
Daniella Rylander et al.
ANNALS OF NEUROLOGY (2010)
Impulse Control Disorders in Parkinson Disease A Cross-Sectional Study of 3090 Patients
Daniel Weintraub et al.
ARCHIVES OF NEUROLOGY (2010)
Relationships between age and late progression of Parkinson's disease: a clinico-pathological study
Peter A. Kempster et al.
BRAIN (2010)
SIRT1 gene is associated with major depressive disorder in the Japanese population
Taro Kishi et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Systematic Analysis of Candidate Genes for Alzheimer's Disease in a French, Genome-Wide Association Study
Geoffroy Laumet et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Two Parkinson's Disease Patients With α-Synuclein Gene Duplication and Rapid Cognitive Decline
Chae Won Shin et al.
MOVEMENT DISORDERS (2010)
Catechol-O-methyltransferase Val158Met and Cognitive Function in Parkinson's Disease
Jeroen Hoogland et al.
MOVEMENT DISORDERS (2010)
Differential Association of Circadian Genes with Mood Disorders: CRY1 and NPAS2 are Associated with Unipolar Major Depression and CLOCK and VIP with Bipolar Disorder
Virginia Soria et al.
NEUROPSYCHOPHARMACOLOGY (2010)
The Path to Personalized Medicine
Margaret A. Hamburg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
CRY2 Is Associated with Depression
Catharina Lavebratt et al.
PLOS ONE (2010)
Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease
Jee-Young Lee et al.
PARKINSONISM & RELATED DISORDERS (2010)
Apolipoprotein E epsilon 4 allele is not associated with age at onset or MMSE of Parkinson's disease in a Korean study
Hye Guk Ryu et al.
PARKINSONISM & RELATED DISORDERS (2010)
Genetics of dopamine receptors and drug addiction: a comprehensive review
Bernard Le Foll et al.
BEHAVIOURAL PHARMACOLOGY (2009)
Targets for neuroprotection in Parkinson's disease
Talene A. Yacoubian et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Haplotype frequencies at the DRD2 locus in populations of the East European Plain
Olga V. Flegontova et al.
BMC GENETICS (2009)
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
Caroline H. Williams-Gray et al.
BRAIN (2009)
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
Juliane Neumann et al.
BRAIN (2009)
Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients
Ying-Zi Liu et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease
F. R. Guerini et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
APOE Alleles in Parkinson Disease and Their Relationship to Cognitive Decline: A Population-based, Longitudinal Study
Martin Wilhelm Kurz et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2009)
Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's Disease
Caroline H. Williams-Gray et al.
JOURNAL OF NEUROLOGY (2009)
BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease
T. Foltynie et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Genetic polymorphism of Angiotensin-Converting Enzyme is not associated with the development of Parkinson's disease and of L-dopa-induced adverse effects
Esterina Pascale et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Motor Complications in Patients Form the German Competence Network on Parkinson's Disease and the DRD3 Ser9Gly Polymorphism
Sebastian Paus et al.
MOVEMENT DISORDERS (2009)
Association of DRD3 and GRIN2B with Impulse Control and Related Behaviors in Parkinson's Disease
Jee-Young Lee et al.
MOVEMENT DISORDERS (2009)
Serotonin and Dopamine Transporter Genes Do Not Influence Depression in Parkinson's Disease
Nadeeka N. W. Dissanayaka et al.
MOVEMENT DISORDERS (2009)
No association between polymorphism of serotonin transporter gene and depression in Parkinson's disease in Chinese
Jing-Lin Zhang et al.
NEUROSCIENCE LETTERS (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Variation in dopamine genes influences responsivity of the human reward system
Jean-Claude Dreher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity
E. E. Forbes et al.
MOLECULAR PSYCHIATRY (2009)
Alpha-synuclein promoter haplotypes and dementia in Parkinson's disease
E. V. De Marco et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2008)
Genomic investigation of α-synuclein multiplication and parkinsonism
Owen A. Ross et al.
ANNALS OF NEUROLOGY (2008)
Pharmacogenetics and the serotonin transporter in late-life depression
Philip Gerretsen et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease
Sebastian Paus et al.
MOVEMENT DISORDERS (2008)
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Mariese A. Hely et al.
MOVEMENT DISORDERS (2008)
The relationship between impulsivity and impulse control disorders in Parkinson's disease
Ioannis U. Isaias et al.
MOVEMENT DISORDERS (2008)
Lack of association of APOE and tau polymorphisms with dementia in Parkinson's disease
Mario Ezquerra et al.
NEUROSCIENCE LETTERS (2008)
Predictors of impulsivity and reward seeking behavior with dopamine agonists
William G. Ondo et al.
PARKINSONISM & RELATED DISORDERS (2008)
The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications
Monika Bialecka et al.
PHARMACOGENETICS AND GENOMICS (2008)
A systematic review of prevalence studies of depression in Parkinson's disease
Jennifer S. A. M. Reijnders et al.
MOVEMENT DISORDERS (2008)
Medication-related impulse control and repetitive behaviors in Parkinson's disease
Valerie Voon et al.
CURRENT OPINION IN NEUROLOGY (2007)
Tau and α-synuclein in susceptibility to, and dementia in, Parkinson's disease
An Goris et al.
ANNALS OF NEUROLOGY (2007)
Levodopa-induced dyskinesias
Giovanni Fabbrini et al.
MOVEMENT DISORDERS (2007)
Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes
Lorenzo Kiferle et al.
NEUROSCIENCE LETTERS (2007)
Catechol O-methyltransferase val158met genotype influences frontoparietal activity during planning in patients with Parkinson's disease
Caroline H. Williams-Gray et al.
JOURNAL OF NEUROSCIENCE (2007)
Phenotypic associations of tau and ApoE in Parkinson's disease
Spiridon Papapetropoulos et al.
NEUROSCIENCE LETTERS (2007)
Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease
Valerie Voon et al.
ARCHIVES OF NEUROLOGY (2007)
Genetic polymorphism of the angiotensin converting enzyme and L-dopa-induced adverse effects in Parkinson's disease
Juei-Jueng Lin et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Lars Bertram et al.
NATURE GENETICS (2007)
Quality of life and depression in Parkinson's disease
Anette Schrag
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Prevalence of repetitive and reward-seeking behaviors in Parkinson disease
V. Voon et al.
NEUROLOGY (2006)
A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor
Freddy Jeanneteau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Association of dopamine agonist use with impulse control disorders in Parkinson disease
Daniel Weintraub et al.
ARCHIVES OF NEUROLOGY (2006)
The lack of association between monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity among men
Nela Pivac et al.
LIFE SCIENCES (2006)
Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease
Judith A. Strong et al.
MOVEMENT DISORDERS (2006)
Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia
N Pankratz et al.
MOVEMENT DISORDERS (2006)
Allelic variation of a functional polymorphism in the serotonin transporter gene and depression in Parkinson's disease
DJ Burn et al.
PARKINSONISM & RELATED DISORDERS (2006)
Apolipoprotein epsilon 4 advances appearance of psychosis in patients with Parkinson's disease
B Feldman et al.
ACTA NEUROLOGICA SCANDINAVICA (2006)
The variable number of tandem repeats element in DATI regulates in vitro dopamine transporter density -: art. no. 55
SH VanNess et al.
BMC GENETICS (2005)
Apolipoprotein E ε4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease:: Relationship to dementia and hallucinations
R Camicioli et al.
MOVEMENT DISORDERS (2005)
Nondopaminergic mechanisms in levodopa-induced dyskinesia
JA Brotchie
MOVEMENT DISORDERS (2005)
Characterization of the in vitro transcriptional activity of polymorphic alleles of the human monoamine oxidase-B gene
P Costa-Mallen et al.
NEUROSCIENCE LETTERS (2005)
Preprohypocretin polymorphisms in Parkinson disease patients reporting Sleep attacks
I Rissling et al.
SLEEP (2005)
The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease
T Foltynie et al.
JOURNAL OF NEUROLOGY (2005)
Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic -: Pharmacodynarnic pattern in patients with Parkinson's disease
M Contin et al.
MOVEMENT DISORDERS (2005)
Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease -: An exploratory study
M Zappia et al.
ARCHIVES OF NEUROLOGY (2005)
Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations
J Jankovic
MOVEMENT DISORDERS (2005)
Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1)
FJ Barrero et al.
PHARMACOGENOMICS JOURNAL (2005)
Dopamine agonists and sleepiness in PD: review of the literature and personal findings
R Manni et al.
SLEEP MEDICINE (2004)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease
J Wang et al.
NEUROSCIENCE LETTERS (2004)
Neuroprotection in Parkinson disease - Mysteries, myths, and misconceptions
AHV Schapira et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Genetic polymorphisms subjects in Parkinson disease subjects with or without hallucinations - An analysis of the cholecystokinin system
JG Goldman et al.
ARCHIVES OF NEUROLOGY (2004)
Planning ability in Parkinson's disease is influenced by the COMT Val158Met polymorphism
T Foltynie et al.
MOVEMENT DISORDERS (2004)
Association of daytime sleepiness with COMT polymorphism in patients with Parkinson disease:: a pilot study
B Frauscher et al.
SLEEP (2004)
Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting sleep attacks
I Rissling et al.
MOVEMENT DISORDERS (2004)
Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease
S Paus et al.
MOVEMENT DISORDERS (2004)
Predictors of sudden onset of sleep in Parkinson's disease
Y Körner et al.
MOVEMENT DISORDERS (2004)
The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease
M Bialecka et al.
ACTA NEUROLOGICA SCANDINAVICA (2004)
Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease
DR Lynch et al.
MOVEMENT DISORDERS (2003)
L-Dopa-induced adverse effects in PD and dopamine transporter gene polymorphism
R Kaiser et al.
NEUROLOGY (2003)
Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease
J Wang et al.
PHARMACOGENETICS (2003)
Genomic medicine: Alzheimer's disease and Parkinson's disease
RL Nussbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Prevalence and characteristics of dementia in Parkinson disease - An 8-year prospective study
D Aarsland et al.
ARCHIVES OF NEUROLOGY (2003)
Association between catechol-O-methyltransferase gene polymorphisms and wearing-off and dyskinesia in Parkinson's disease
M Watanabe et al.
NEUROPSYCHOBIOLOGY (2003)
MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD
MA Hernán et al.
NEUROLOGY (2002)
COMT genotype and effectiveness of entacapone in patients with fluctuating Parkinson's disease
MS Lee et al.
NEUROLOGY (2002)
Dopamine D5 receptor gene polymorphism and the risk of levodopa-induced motor fluctuations in patients with Parkinson's disease
J Wang et al.
NEUROSCIENCE LETTERS (2001)
Association study of dopamine D2, D3 receptor gene polymorphisms with motor fluctuations in PD
J Wang et al.
NEUROLOGY (2001)
Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease
R Mössner et al.
MOLECULAR PSYCHIATRY (2001)
Sleep attacks and antiparkinsonian drugs: A pilot prospective pharmacoepidemiologic study
JL Montastruc et al.
CLINICAL NEUROPHARMACOLOGY (2001)
The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans
D Martinez et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Genotypes of catechol-O-methyltransferase and response to levodopa treatment in patients with Parkinson's disease
MS Lee et al.
NEUROSCIENCE LETTERS (2001)
Genetic variation analysis in Parkinson disease patients with and without hallucinations - Case-control study
CG Goetz et al.
ARCHIVES OF NEUROLOGY (2001)
Prediction of dopamine transporter binding availability by genotype: A preliminary report
LK Jacobsen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's disease
DJ Chong et al.
CLINICAL NEUROPHARMACOLOGY (2000)
Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease
AJ Makoff et al.
PHARMACOGENETICS (2000)
Platelet monoamine oxidase activity is related to MAOB intron 13 genotype
H Garpenstrand et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
分享论文
